Literature DB >> 16858500

Liver transplantation for cirrhosis in cystic fibrosis.

T Lamireau1, S Martin, M Lallier, J E Marcotte, F Alvarez.   

Abstract

BACKGROUND: Liver disease is the third most common cause of death in children with cystic fibrosis (CF). Liver transplantation is an effective treatment in children with hepatic failure. AIMS: The objective of the present study was to review the indications and postoperative course of hepatic transplantation in a cystic fibrosis population. PATIENTS: Five children with CF, at a mean age of 16.5 years, underwent liver transplantation.
RESULTS: All patients showed cirrhosis, portal hypertension and hepatic failure. The main postoperative complication was ascites refractory to treatment in two patients. No significant deterioration of the pulmonary function was noted. Two patients died, one of Hodgkin lymphoma and the other of progressive pulmonary failure.
CONCLUSION: Liver transplantation was indicated in children with CF when hepatic failure and/or severe portal hypertension was present with well-preserved pulmonary function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858500      PMCID: PMC2659915          DOI: 10.1155/2006/539345

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  28 in total

1.  Biliary complications in liver transplantation for cystic fibrosis.

Authors:  R Chavez-Cartaya; M Drage; N V Jamieson; P Friend; G Noble-Jamieson; R Levy; N Barnes; R Calne
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

2.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

3.  Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E.

Authors:  R J Sokol; K E Johnson; F M Karrer; M R Narkewicz; D Smith; I Kam
Journal:  Lancet       Date:  1991-07-27       Impact factor: 79.321

4.  Liver transplantation in cystic fibrosis.

Authors:  L A Mieles; D Orenstein; L Teperman; L Podesta; B Koneru; T E Starzl
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

5.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; J Valente; N D Barnes; P J Friend; N V Jamieson; A Rasmussen; R Y Calne
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

6.  Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.

Authors:  J A Cohn; T V Strong; M R Picciotto; A C Nairn; F S Collins; J G Fitz
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

7.  Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis.

Authors:  P Greally; M J Hussain; D Vergani; J F Price
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

Review 8.  Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.

Authors:  Jonathan A Fridell; Geoffrey J Bond; George V Mazariegos; David M Orenstein; Ashokkumar Jain; Rakesh Sindhi; Jonathan D Finder; Ernesto Molmenti; Jorge Reyes
Journal:  J Pediatr Surg       Date:  2003-08       Impact factor: 2.545

9.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

10.  Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

Authors:  J Feigelson; C Anagnostopoulos; M Poquet; Y Pecau; A Munck; J Navarro
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

View more
  5 in total

1.  Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Authors:  Wen Ye; Michael R Narkewicz; Daniel H Leung; Wikrom Karnsakul; Karen F Murray; Estella M Alonso; John C Magee; Sarah Jane Schwarzenberg; Alexander Weymann; Jean P Molleston
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

Review 2.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

Review 3.  Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases.

Authors:  Adriana Haack; Giselle Gonçalves Aragão; Maria Rita Carvalho Garbi Novaes
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

4.  Cystic fibrosis-related liver disease: a single-center experience.

Authors:  Paula Catarino Costa; Celeste Canha Barreto; Luisa Pereira; Maria Luisa Lobo; Maria Adília Costa; Ana Isabel Gouveia Lopes
Journal:  Pediatr Rep       Date:  2011-10-17

5.  Etiology and management of hemorrhagic complications of portal hypertension in children.

Authors:  Alejandro Costaguta; Fernando Alvarez
Journal:  Int J Hepatol       Date:  2012-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.